首页> 外文期刊>Control Theory & Applications, IET >Real-time control of human coagulation
【24h】

Real-time control of human coagulation

机译:人体凝血的实时控制

获取原文
获取原文并翻译 | 示例
           

摘要

In previous work, the authors showed that the dynamics of human blood clotting could be fruitfully modelled and simulated as a hybrid system (HS), that is, one with interacting continuous and discrete parts. Here, the authors show that, although a complete analysis of the HS is (computationally) infeasible, analysis and control techniques can indeed be applied to a large, critical subsystem a set of about 100 ordinary differential equations. The theory is outlined behind the control techniques and then demonstrate in a series of simulations their application to control of pathological blood clotting, both hypercoagulatory (factor-V Leiden) and hypocoagulatory (haemophilia A). In particular, steering is simulated during a clotting event of the crucial blood-protein thrombin, via the controlled injection of (recombinant) factor VIII (for h??mophilia) or the anti-coagulant heparin (for FV Leiden). It remains to remedy the shortcomings of this control technique, and to extend it to the remainder of the HS of the previous work; methods for these are proposed, and addressed in a subsequent article.
机译:在先前的工作中,作者表明,可以将人类凝血的动力学建模和模拟为一种混合系统(HS),即具有相互作用的连续和离散部分的混合系统。在这里,作者表明,尽管对HS进行完整的分析(在计算上)是不可行的,但分析和控制技术的确可以应用于大约100个常微分方程组的大型关键子系统。该理论概述于控制技术的背后,然后在一系列模拟中证明了它们在控制高凝(因子-V Leiden)和低凝(A型血友病)病理性血液凝结中的应用。特别是,在关键的血液蛋白凝血酶凝结过程中,通过(重组)凝血因子VIII(对于嗜血性粒细胞增多症)或抗凝肝素(对于FV Leiden)的受控注射来模拟转向。有必要纠正这种控制技术的缺点,并将其扩展到先前工作的HS的其余部分。提出了这些方法,并在随后的文章中讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号